| Product NDC: | 0615-4536 |
| Proprietary Name: | Bumetanide |
| Non Proprietary Name: | Bumetanide |
| Active Ingredient(s): | 1 mg/1 & nbsp; Bumetanide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0615-4536 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074225 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20071016 |
| Package NDC: | 0615-4536-31 |
| Package Description: | 31 TABLET in 1 BLISTER PACK (0615-4536-31) |
| NDC Code | 0615-4536-31 |
| Proprietary Name | Bumetanide |
| Package Description | 31 TABLET in 1 BLISTER PACK (0615-4536-31) |
| Product NDC | 0615-4536 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bumetanide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20071016 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | BUMETANIDE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |